Breaking News

PackGene partners Kudo Bio on customised mRNA manufacturing

The two companies have partnered to develop end-to-end coverage of mRNA development, from gene to mRNA, lipid nanoparticle (LNP) formulation develo...

Intravaac shares publication of OMV-based intranasal vaccine review

The CDMO has shared the publication in Current Opinion in Immunology regarding the efficacy its OMV-based vaccines, administered intranasally

Mitsubishi signs agreement with Roquette for Qualicaps shares

Pharmaceutical excipients expert Roquette has signed an agreement with the MCG Group for the shares of hard capsule manufacturer Qualicaps

Taking a decentralised approach to commercialising cell and gene therapies

With the medical world facing some of the worst cancer drug shortages in history, many thousands of patients are not getting the treatments they ne...

Partnership speeds the development of pressurised metered dose inhalers

Honeywell has partnered with CDMO Recipharm on a commercial partnership that will speed the development of pressurised metered dose inhalers

BDD secures further round of investment for drug delivery tech

The company has secured a further round of investment for £2 million (USD $2.5 million) to aid its expansion in response to growing demand for drug...

What's in an FDA approval? How a start-up company gets its drug to market

The FDA wields a supreme amount of power in the regulatory realm of the pharmaceutical industry. For smaller start-ups or those newer to the indust...

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use...

NIH selects Exothera for manufacturing of Covid intranasal vaccine

The CDMO Exothera has been selected by the National Institutes of Health to develop the manufacturing process for its intranasal vaccine against SA...

TAE Life Sciences to distribute drug for boron neutron capture therapy

Biddle Sawyer have agreed with TAE Life Sciences to be the supplier of a novel boronated amino acid analog drug for boron neutron capture therapy

Establishing a rigorous and robust approach to topical drug product process development: part II

The aim of process development is to establish optimal process parameters and conditions for future large-scale batches or commercialisation, ensur...

Inspiration from unexpected places

How pharmaceutical companies can learn from advances in nicotine delivery

Spexis secures funding for cystic fibrosis infection treatment

The company has confirmed funding of USD $2.5m to go towards upcoming Phase 3 studies for ColiFin, an inhaled therapeutic to counter chronic infect...

Establishing a rigorous and robust approach to topical drug product process development: part I

The aim of process development is to establish optimal process parameters and conditions for future large-scale batches or commercialisation, ensur...

Full details from Calliditas Therapeutics’ Phase 3 study released

Calliditas Therapeutics has announced publication in The Lancet of the full data from the Phase 3 NefIgArd Study with Nefecon delayed release capsu...

Adding a new chapter to the history of capsule-based drug delivery

For more than 100 years, capsules have consisted of two pieces (a body and a cap). Nutritional or pharmaceutical ingredients are dosed into the bod...

In Brief

Vetter earns Frost & Sullivan’s Customer Value Award for the third time

Nanoform and Celanese demonstrate enhanced drug delivery through the power of smaller implants

Aptamer and Neuro-Bio collaborate on Alzheimer’s disease diagnostic

Enteric delivery of my API: how to make it right?

ASM Research Chemicals launches development packs for APIs

SGS launches pathway to accelerate molecules from preclinical to clinical formulation

Microsphere Summit 2023

Supporting new applications for inhaled medicines

Join ProtaGene and ADRES for a joint webinar on regulatory and analytical aspects of comparability in biologics development

CPhI Worldwide 2018

GEA optimises design program for refrigeration plants

Proprietary AAV gene therapy product line to launch

Copley launches automated impaction surface coating and drug dissolution solution

PharmaPack

Increasing process efficiency with X-platform bioreactors by Cytiva

Tillotts launches Octasa tablets in Canada

Aptamer launches reagent solution for immunohistochemistry

Pre-Filled Syringes Europe 2017

Polyplus introduces LipidBrick for LNP formulation in mRNA therapeutics

ILC Dover adds platinum-cured silicone tubing

GEA supports Aspis with solution for the circular economy

APGI Workshop on Oral Controlled Release

Copley launches the new DUSA Shaker DTS 100i

Gerresheimer enters joint venture with Corning

Phillips-Medisize expands product portfolio with launch of a pen injector

Orphan Drugs & Rare Diseases Global Congress 2017 Europe